Medical treatment of uric acid urolithiasis

被引:0
|
作者
Normand, M. [1 ]
机构
[1] Hop Pr St Martin, Serv Nephrol, F-33600 Pessac, France
来源
PROGRES EN UROLOGIE | 2013年 / 23卷
关键词
Uric acid kidney stone; Metabolic syndrome; Potassium citrate; Urinary pH; URINARY PH; STONE; CITRATE; PREVALENCE;
D O I
10.1016/j.fpurol.2012.11.003
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The prevalence of uric kidney stone increases regularly, due to its high correlation with obesity, HTA, metabolic syndrome, diabetes and elderly age. The surgical treatment of urolithiasis may not be always easy, and the lithotripsy has a very low efficiency. So, an appropriate medical prescription, with a good patient observance, is very effective regarding kidney stone dissolution as well as for recurrence prevention. The urinary pH is acidic, which is the main factor of lithogenesis. It must be corrected by the alkalization of the urines. The potassium citrate treatment is very efficient, and has low side effects. It must be prescribed diluted in 1.5 L of water, to be effective all over the day and to avoid gastro-intestinal disorders. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:F77 / F83
页数:7
相关论文
共 50 条
  • [31] Uric acid in metabolic syndrome: Does uric acid have a definitive role?
    Copur, Sidar
    Demiray, Atalay
    Kanbay, Mehmet
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 103 : 4 - 12
  • [32] Combined Supplementation with Glycine and Tryptophan Reduces Purine-Induced Serum Uric Acid Elevation by Accelerating Urinary Uric Acid Excretion: A Randomized, Single-Blind, Placebo-Controlled, Crossover Study
    Oshima, Shunji
    Shiiya, Sachie
    Nakamura, Yasunori
    NUTRIENTS, 2019, 11 (11)
  • [33] Chronic Hyperuricemia, Uric Acid Deposit and Cardiovascular Risk
    Grassi, Davide
    Ferri, Livia
    Desideri, Giovambattista
    Di Giosia, Paolo
    Cheli, Paola
    Del Pinto, Rita
    Properzi, Giuliana
    Ferri, Claudio
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (13) : 2432 - 2438
  • [34] Effect of thiazolidinedione therapy on the risk of uric acid stones
    Asplin, John R.
    Goldfarb, David S.
    KIDNEY INTERNATIONAL, 2019, 95 (05) : 1022 - 1024
  • [35] Uric acid and the cardiovascular profile of African and Caucasian men
    Palmer, I. M.
    Schutte, A. E.
    Huisman, H. W.
    JOURNAL OF HUMAN HYPERTENSION, 2010, 24 (10) : 639 - 645
  • [36] Biochemical and dietary factors of uric acid stone formation
    Trinchieri, Alberto
    Montanari, Emanuele
    UROLITHIASIS, 2018, 46 (02) : 167 - 172
  • [37] Biochemical and dietary factors of uric acid stone formation
    Alberto Trinchieri
    Emanuele Montanari
    Urolithiasis, 2018, 46 : 167 - 172
  • [38] Who makes uric acid stones and why-observations from a renal stones clinic
    Stansbridge, Elizabeth M.
    Griffin, Damian G.
    Walker, Valerie
    JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (05) : 426 - 431
  • [39] Protein Intake and High Uric Acid Stone Risk
    Montgomery, Tinika A.
    Nair, Hari R.
    Phadke, Manali
    Morhardt, Erin
    Ludvigson, Adam
    Motamedinia, Piruz
    Singh, Dinesh
    Dahl, Neera K.
    KIDNEY MEDICINE, 2024, 6 (09)
  • [40] The importance of potassium citrate and potassium bicarbonate in the treatment of uric acid renal stones
    Barbera, Michele
    Tsirgiotis, Andreas
    Barbera, Mauro
    Paola, Quintino
    ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2016, 88 (04) : 341 - 342